Yanwei Bi
Impact in
-
- Hepatitis C virus research
-
- Herpesvirus Infections and Treatments
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Cytomegalovirus and herpesvirus research
Papers in
-
- CRISPR and Genetic Engineering 3
-
- Herpesvirus Infections and Treatments 3
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Wei Cun (7 shared papers)Qihan Li (3 shared papers)Yadong Li (2 shared papers)Le Sun (2 shared papers)Zhihua Li (3 shared papers)Chen Ding (2 shared papers)Dandan Gao (1 shared paper)Xiaofei Yu (1 shared paper)
- Journals
- Virus Research (1 paper)The Journal of Immunology (1 paper)PLoS Pathogens (1 paper)Cell Proliferation (1 paper)Journal of General Virology (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Yanwei Bi
14 papers receiving 318 citations
Peers
Comparison fields: 5 of 52
- Hepatology 31
- Epidemiology 131
- Virology 14
- Molecular Biology 190
- Genetics 66
Countries citing papers authored by Yanwei Bi
This map shows the geographic impact of Yanwei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Bi more than expected).
Fields of papers citing papers by Yanwei Bi
This network shows the impact of papers produced by Yanwei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Bi. The network helps show where Yanwei Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanwei Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 127 | |
| 2 | 2006 | 44 | |
| 3 | 2018 | 33 | |
| 4 | 2019 | 22 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 18 | |
| 7 | 2017 | 18 | |
| 8 | 2017 | 13 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2021 | 2 | |
| 14 | 2025 | 1 |
About Yanwei Bi
Yanwei Bi is a scholar working on Molecular Biology, Epidemiology, Immunology, Infectious Diseases and Oncology, having authored 14 papers that have together received 323 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), Herpesvirus Infections and Treatments (3 papers), Plant Virus Research Studies (2 papers), Virus-based gene therapy research (2 papers), Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Lymphatic System and Diseases (1 paper). The work is most often cited by research in Hepatology (31 citations), Epidemiology (131 citations), Virology (14 citations), Molecular Biology (190 citations) and Genetics (66 citations). Yanwei Bi has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Wei Cun, Qihan Li, Yadong Li, Le Sun, Zhihua Li, Chen Ding, Dandan Gao, Xiaofei Yu, Bin Zhou and Man‐Chiu Poon. Their work appears in journals such as Virus Research, The Journal of Immunology, PLoS Pathogens, Cell Proliferation and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.